Company Number: 14359836

Analysis Date: 2025-07-29 12:10 UTC

1. Risk Rating: HIGH
   Justification: The company shows extremely tight liquidity with current liabilities nearly equal to current assets, resulting in negative net working capital and minimal net assets. The large stock/work-in-progress figure relative to cash and debtors, combined with significant short-term creditors, raises concerns about cash flow sufficiency and operational funding.

2. Key Concerns:

• Liquidity strain: Current liabilities (£395,481) exceed current assets (£394,632) causing net current liabilities of £849, indicating potential difficulty meeting short-term obligations.
• Stock valuation risk: £385,000 classified as "work in progress" stocks may be illiquid or subject to write-downs, which could impair asset realizability.
• Minimal equity cushion: Net assets and shareholders’ funds stand at only £418, reflecting negligible capital buffer to absorb losses or fund growth.

3. Positive Indicators:

• Compliance: No overdue filings for accounts or confirmation statements, indicating good regulatory adherence so far.
• Established management: Five directors with relevant professional occupations, including research scientists and consultants, suggesting operational expertise.
• Small company exemption: Filing under Total Exemption Full, consistent with size and complexity, reducing administrative burden.

4. Due Diligence Notes:

• Investigate nature and realizability of £385,000 work-in-progress stock to assess true liquidity and valuation accuracy.
• Review creditor aging and terms, especially the large "Other Creditors" (£376,374), to understand payment pressures and creditor relationships.
• Obtain profit and loss information (not filed) to evaluate operational performance and cash flow trends since incorporation.
• Assess directors’ plans for funding or managing working capital deficits.
• Confirm no director disqualifications or governance issues beyond public data.